Literature DB >> 9663424

Paclitaxel-induced cell-mediated hypersensitivity pneumonitis. Diagnosis using leukocyte migration test, bronchoalveolar lavage and transbronchial lung biopsy.

K Fujimori1, A Yokoyama, Y Kurita, K Uno, N Saijo.   

Abstract

A 73-year-old man with mild inactive interstitial pneumonitis and non-small cell bronchogenic carcinoma developed a cell-mediated hypersensitivity pneumonitis within 15 days following a second exposure to paclitaxel. Histological features of transbronchial lung biopsy were consistent with interstitial pneumonitis. Bronchoalveolar lavage showed increased lymphocytes and eosinophils, and decreased helper/suppressor T lymphocyte ratio. Leukocyte migration inhibitory test was positive for paclitaxel. These results support the possibility that paclitaxel-induced pneumonitis is due to delayed type hypersensitivity; they also support the hypothesis of a central role of T lymphocytes in drug-induced pneumonitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663424     DOI: 10.1159/000011873

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  12 in total

1.  Suspected paclitaxel-induced pneumonitis.

Authors:  Kohei Shitara; Eiji Ishii; Makoto Kondo; Yuh Sakata
Journal:  Gastric Cancer       Date:  2006-11-24       Impact factor: 7.370

Review 2.  Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.

Authors:  Matthieu Picard; Mariana C Castells
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 3.  Anticancer therapy and lung injury: molecular mechanisms.

Authors:  Li Li; Henry Mok; Pavan Jhaveri; Mark D Bonnen; Andrew G Sikora; N Tony Eissa; Ritsuko U Komaki; Yohannes T Ghebre
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-23       Impact factor: 4.512

Review 4.  Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches.

Authors:  Osamu Matsuno
Journal:  Respir Res       Date:  2012-05-31

5.  Delayed Paclitaxel-trastuzumab-induced interstitial pneumonitis in breast cancer.

Authors:  Omalkhair Abulkhair; Wael El Melouk
Journal:  Case Rep Oncol       Date:  2011-04-02

6.  Life-threatening hypersensitivity pneumonitis induced by docetaxel (taxotere).

Authors:  G S Wang; K Y Yang; R P Perng
Journal:  Br J Cancer       Date:  2001-11-02       Impact factor: 7.640

7.  Hypersensitivity Pneumonitis Caused by Cephalosporins With Identical R1 Side Chains.

Authors:  Sang Hee Lee; Mi Hyun Kim; Kwangha Lee; Eun Jung Jo; Hye Kyung Park
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-25       Impact factor: 5.764

8.  Case Report: Paclitaxel-Induced Pneumonitis in Early Breast Cancer: A Single Institution Experience and Review.

Authors:  Luke Ardolino; Brandon Lau; Isabella Wilson; Julia Chen; Linda Borella; Emily Stone; Elgene Lim
Journal:  Front Oncol       Date:  2021-06-23       Impact factor: 6.244

9.  Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.

Authors:  I A McNeish; E J Kanfer; R Haynes; C Giles; S J Harland; D Driver; G J S Rustin; E S Newlands; M J Seckl
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640

Review 10.  Radiation-induced lung toxicity - cellular and molecular mechanisms of pathogenesis, management, and literature review.

Authors:  Lukas Käsmann; Alexander Dietrich; Claudia A Staab-Weijnitz; Farkhad Manapov; Jürgen Behr; Andreas Rimner; Branislav Jeremic; Suresh Senan; Dirk De Ruysscher; Kirsten Lauber; Claus Belka
Journal:  Radiat Oncol       Date:  2020-09-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.